«QD Group

Below is an extended QD Group news listing. Click here to return to the QD Group main Biocorporate entry.

BioNews Results for QD Group:
Oral Gefitinib as Effective as Injected Docetaxel for Survival of Patients With NSCLC Doctors Guide: Nov 21 2008 10:50PM Matching: qd group
Lipid effects in the ARTEMIS and TITAN trials: effects of demographics, HIV disease stage, treatment arm and l National AIDS Treatment Advocacy Project: Nov 18 2008 8:03AM Matching: qd group
Safety and antiviral activity of BI 201335, a new HCV NS3 protease inhibitor, in combination therapy with pegi National AIDS Treatment Advocacy Project: Nov 16 2008 9:59AM Matching: qd group
Efficacy and safety of switching from Lopinavir/r to Atazanavir/r in suppressed patients receiving a LPV/r con National AIDS Treatment Advocacy Project: Nov 14 2008 12:03AM Matching: qd group
Five-Day Moxifloxacin Can Provide Benefits for Acute Bacterial Sinusitis: Presented at ACAAI Doctors Guide: Nov 12 2008 10:23PM Matching: qd group
Safety, Tolerability, and Pharmacokinetic Data Following Single- and Multiple-Dose Administration of MK-7009, National AIDS Treatment Advocacy Project: Nov 11 2008 3:57AM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented DiGiTAL50: Nov 10 2008 7:09PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented Genetic Engineering News: Nov 10 2008 1:38PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented Earthtimes.org: Nov 10 2008 1:06PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented Stockwatch: Nov 10 2008 1:05PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented FinanzNachrichten.de: Nov 10 2008 1:03PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented Calibre Macro World: Nov 10 2008 12:51PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA PR inside: Nov 10 2008 1:35PM Matching: qd group
Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented Globe Investor: Nov 10 2008 1:03PM Matching: qd group
Safety and antiviral activity of TMC435350 in treatment-naive genotype 1 HCV-infected patients National AIDS Treatment Advocacy Project: Nov 5 2008 2:15AM Matching: qd group

«QD Group

This page contained an extended QD Group news listing. Click here to return to the QD Group main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.